Drugs / Spectrum Plasma yFFP
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT04202757 Comparator | Sep 2018 → Aug 2019 | Parkinson disease | The Neurology Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Spectrum Plasma yFFP | “12.5 ml/kg intravenous Spectrum Plasma yFFP, per each of two infusions (25 ml/kg total), in combination with ongoing normal standard treatment.” NCT04202757 ↗ |
| Known as | Young Fresh Frozen Plasma (yFFP) | “Young Fresh Frozen Plasma (yFFP)” NCT04202757 ↗ |
| Route | Intravenous | “12.5 ml/kg intravenous Spectrum Plasma yFFP, per each of two infusions (25 ml/kg total), in combination with ongoing normal standard treatment.” NCT04202757 ↗ |